இயல்பு கடந்த கருப்பை இரத்தப்போக்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இயல்பு கடந்த கருப்பை இரத்தப்போக்கு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இயல்பு கடந்த கருப்பை இரத்தப்போக்கு Today - Breaking & Trending Today

Femtech startup OCON Healthcare announces last patient in phase IIa clinical study, evaluating its intrauterine drug delivery platform IUB SEAD, a non-invasive treatment for abnormal uterine bleeding (AUB)

(1)
The trial assesses the safety and efficacy of the IUB SEAD, a disruptive treatment for AUB. In this study, 50% of the participating patients have reached the End of the Study point, demonstrating a significant reduction in bleeding, avoiding the need to undergo invasive uterine ablation procedures or even a hysterectomy
MODIIN, Israel, March 4, 2021 /PRNewswire/
OCON Healthcare, a women s health company which develops, manufactures and commercializes an innovative 3D intrauterine drug delivery technology based on its patented IUB
TM (Intra Uterine Ball) platform, today announced it had completed enrollment of its Phase IIa clinical study evaluating its intrauterine drug delivery platform IUB SEAD,a non-invasive treatment for abnormal uterine bleeding (AUB). ....

Israel General , Ravit Levrann , Kostenloser Wertpapierhandel , Sergio Haimovich , Intra Uterine Ball , Abnormal Uterine Bleeding , Chief Medical Officer , Health Care , இஸ்ரேல் ஜநரல் , இன்ட்ரா கருப்பை பந்து , இயல்பு கடந்த கருப்பை இரத்தப்போக்கு , தலைமை மருத்துவ அதிகாரி , ஆரோக்கியம் பராமரிப்பு , இயல்பு கடந்த ,

FemTech startup OCON Healthcare completes funding round and appoints Dr. Anula Jayasuriya to Chairwoman

, a women s health company which develops, manufactures and commercializes innovative 3D intrauterine devices based on its patented IUB™
(Intra-Uterine Ball) platform, announced that it has completed a USA-focused funding round led by Rhia Ventures, to bring its IUB Ballerine® contraceptive and IUB SEAD™ point-of-care therapy for Abnormal Uterine Bleeding (AUB), to the US market, and to expand Phase II clinical trials for the IUB SEAD™.
OCON Healthcare completes funding round towards US market. OCON’s IUB Ballerine® is the first ever 3D spherical copper intrauterine contraceptive with a superior safety profile
OCON also appointment California-based Dr. Anula Jayasuriya to Chairwoman, an accomplished private equity and VC leader with over 30 years of business, scientific and medical expertise. I m excited to be appointed chairwoman of the OCON board, said ....

Israel General , Ravit Levrann , Keren Leshem , Stasia Obremskey , Israeli Innovation Authority , Intra Uterine Ball , United States Focused , Rhia Ventures , Abnormal Uterine Bleeding , Anula Jayasuriya , Astia Angels , Israeli Innovation , Managing Director , Rhia Venture , இஸ்ரேல் ஜநரல் , கர்ரந் லேஷெம் , இஸ்ரேலி கண்டுபிடிப்பு அதிகாரம் , இன்ட்ரா கருப்பை பந்து , ஒன்றுபட்டது மாநிலங்களில் கவனம் , இயல்பு கடந்த கருப்பை இரத்தப்போக்கு , ஆஸ்தியா தேவதூதர்கள் , இஸ்ரேலி கண்டுபிடிப்பு , நிர்வகித்தல் இயக்குனர் ,